v3.26.1
SHAREHOLDERS' EQUITY - Narrative (Details)
12 Months Ended 85 Months Ended
Jul. 18, 2021
Feb. 04, 2020
USD ($)
sales_agent
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
May 21, 2024
USD ($)
May 20, 2024
USD ($)
Aug. 02, 2022
USD ($)
Aug. 01, 2022
USD ($)
Aug. 31, 2021
USD ($)
Jul. 28, 2021
USD ($)
May 26, 2021
USD ($)
Mar. 04, 2019
USD ($)
Subsidiary or Equity Method Investee [Line Items]                          
Repurchase authorized amount                   $ 20,000,000 $ 20,000,000    
Restricted Stock | 2010 Plan                          
Subsidiary or Equity Method Investee [Line Items]                          
Right to grant period (in years) 10 years                        
Equity ATM Program                          
Subsidiary or Equity Method Investee [Line Items]                          
Maximum consideration threshold   $ 100,000,000.0       $ 1,000,000,000.0 $ 650,000,000.0 $ 650,000,000.0 $ 250,000,000.0     $ 250,000,000.0 $ 50,000,000.0
Number of additional sales agents | sales_agent   2                      
Gross sales commission percentage   2.00%                   1.50%  
Number of shares sold (in shares) | shares     7,396,112 7,694,740 40,437,289                
Weighted average price per share (in usd per share) | $ / shares     $ 21.65 $ 23.54 $ 21.52                
Gross proceeds received     $ 160,123,000 $ 181,112,000 $ 870,100,000                
Net proceeds received     157,819,000 $ 178,493,000 856,900,000                
Available under the equity ATM program     $ 129,900,000   $ 129,900,000